Mercado de insuficiencia pancreática exocrina: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPMD00002573
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

RESUMEN DEL MERCADO

La insuficiencia pancreática exocrina (EPI) es un tipo de afección médica en la que el páncreas no puede producir suficientes enzimas digestivas, lo que provoca malabsorción. de nutrientes y desnutrición. La EPI puede ser causada por varios factores, incluida la pancreatitis crónica, el cáncer de páncreas y la fibrosis quística. La EPI se trata comúnmente con terapia de reemplazo enzimático (TRE), que reemplaza las enzimas digestivas faltantes con suplementos orales. La ERT es una forma eficaz de mejorar la absorción de nutrientes y aliviar los síntomas, lo que la convierte en una opción de tratamiento valiosa para las personas con EPI. Los usuarios finales de los tratamientos EPI suelen ser personas a las que se les ha diagnosticado EPI, así como proveedores de atención médica que recetan estos tratamientos. ERT es una herramienta importante para prevenir la desnutrición y mejorar la calidad de vida de las personas con EPI. El futuro del mercado de EPI parece prometedor, impulsado por el creciente reconocimiento de los beneficios de la ERT y los avances en las opciones de tratamiento.

ÁMBITO DEL MERCADO

El "Análisis exocrino global hasta 2031" es un estudio especializado y en profundidad de la industria de dispositivos médicos con un enfoque en la tendencia exocrina. El informe tiene como objetivo proporcionar una descripción general del exocrino global con una segmentación detallada del mercado por tipo, usuario final y geografía. Se espera que el exocrino global sea testigo de un alto crecimiento durante el período previsto. El informe proporciona estadísticas clave sobre el estado del mercado de los principales actores del mercado y ofrece tendencias y oportunidades clave en el sector exocrino.

SEGMENTACIÓN DEL MERCADO

El mercado mundial de máquinas de anestesia está segmentado según el producto y el usuario final. El segmento de productos incluye máquinas de anestesia independientes y máquinas de anestesia portátiles. Según el usuario final, el mercado de insuficiencia pancreática exocrina se clasifica en hospitales, clínicas y centros quirúrgicos ambulatorios.

DINÁMICA DEL MERCADO

El mercado de insuficiencia pancreática exocrina Es probable que se anticipe un crecimiento a un ritmo significativo en los años previstos, debido a factores determinantes como el aumento de la prevalencia de trastornos gastrointestinales, colitis ulcerosa y crecimiento bacteriano del intestino delgado, entre otros. Además, es probable que la creciente prevalencia de la fibrosis quística, el cáncer de páncreas y la diabetes hagan crecer el mercado en los años previstos. Es probable que el mercado busque diversas oportunidades para desarrollar productos innovadores y de prueba sencilla para tratar la insuficiencia pancreática exocrina.

El mercado mundial de insuficiencia pancreática exocrina está segmentado según el tipo y el usuario final. El segmento de tipo básico incluye imágenes y pruebas de muestra. El segmento de imágenes se divide a su vez en subsegmentos, como tomografía computarizada, ecografía endoscópica (USE), resonancia magnética (MRI) y otros. De manera similar, la prueba de muestra se divide a su vez en análisis de sangre, prueba fecal y prueba de función pancreática. Según el usuario final, el segmento se clasifica en hospitales, laboratorios de diagnóstico y otros.

El informe proporciona una descripción detallada de la industria que incluye información tanto cualitativa como cuantitativa. Proporciona una descripción general y una previsión del mercado mundial de insuficiencia pancreática exocrina según el tipo, el usuario final y la geografía. También proporciona el tamaño del mercado y el pronóstico hasta 2031 para el mercado general de insuficiencia pancreática exocrina con respecto a cinco regiones principales, a saber; América del Norte, Europa, Asia-Pacífico (APAC), Medio Oriente y África (MEA) y Sur y África. Centroamérica. El mercado de cada región se subsegmenta posteriormente en los respectivos países y segmentos. El informe cubre el análisis y el pronóstico de 13 condados a nivel mundial junto con las tendencias actuales y las oportunidades que prevalecen en la región.

Se espera que América del Norte contribuya a la mayor participación en el mercado de insuficiencia pancreática exocrina en los próximos años, debido a factores como el aumento de la incidencia de la infección bacteriana, el aumento de la prevalencia de la insuficiencia pancreática exocrina. insuficiencia pancreática y más. Se prevé que el mercado de Europa y Asia Pacífico tenga una gran cuota de mercado después de América del Norte. Es probable que el aumento de la población geriátrica en estas regiones contribuya a la importante tasa de crecimiento del mercado.

JUGADORES DEL MERCADO

El informe también incluye los perfiles de las principales empresas fabricantes del mercado de Insuficiencia pancreática exocrina junto con su análisis FODA y estrategias de mercado. Además, el informe se centra en los principales actores de la industria con información como perfiles de empresas, productos y servicios ofrecidos, información financiera de los últimos 3 años y desarrollos clave en los últimos cinco años. Algunos de los actores clave que influyen en el mercado son Medtronic, General Electric Company, Koninklijke Philips NV, Siemens Healthcare GmbH, Canon Medical Systems, USA, ThermoFisher Scientific Inc., ScheBo Biotech AG, Hologic Inc., Immunostics, Inc. y Biohit Oyj.

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies
1. Medtronic
2. General Electric Company
3. Koninklijke Philips N.V.
4. Siemens Healthcare GmbH
5. Canon Medical Systems, USA
6. ThermoFisher Scientific Inc.
7. ScheBo Biotech AG
8. Hologic Inc.
9. Immunostics, Inc.
10. Biohit Oyj


Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.